Matthew Hazelett

Cybersecurity Policy Analyst

Food and Drug Administration (FDA) | Implantable Electrophysiology Devices Branch (IEDB) at the Center for Devices and Radiological Health (CDRH)

Speaker Sessions

September 21, 2023 | 03:15 PM (PDT) - 04:15 PM (PDT)

About Matthew Hazelett

Matthew Hazelett started at the Food and Drug Administration as a biomedical engineer within the Implantable Electrophysiology Devices Branch (IEDB) at the Center for Devices and Radiological Health (CDRH). His review areas included pacemakers, defibrillators, leads, and supporting devices (programmers, home monitors, etc.). Since starting at FDA, he developed a review focus in cybersecurity, participates in cybersecurity guidance development, and supports cybersecurity vulnerability assessments and premarket reviews across CDRH. He started his position as the Cybersecurity Policy Analyst in the Office of Product Evaluation and Quality (OPEQ) in February 2020. His role is focused on premarket and postmarket cybersecurity policy development and implementation across the clinical review offices. He also serves as a Digital Health Center of Excellence Program Director for the OPEQ Cybersecurity Focal Point Program.

Matthew earned a B.S. in biomedical engineering from the University of Rochester where he focused in electrical signals and systems. After graduation, he worked for a medical device research and development company in New Hampshire as a Test Engineer and then Test Manager overseeing device verification and validation testing.

Disclosures

No relevant financial relationships to disclose.